HM
HealthCor Management Portfolio holdings
AUM
$109M
1-Year Est. Return
10.64%
This Fund
S&P 500
1 Year Est. Return
+10.64%
AUM
$109M
AUM Growth
-$690M
(-86%)
Holding
65
Top Buys
| 1 | +$7.45M | |
| 2 | +$3.61M | |
| 3 | +$2.28M | |
| 4 |
Intuitive Surgical
ISRG
|
+$1.4M |
| 5 |
Hyperfine
HYPR
|
+$1.03M |
Top Sells
| 1 | +$41.6M | |
| 2 | +$41.1M | |
| 3 | +$37.1M | |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$36.7M |
| 5 |
Eli Lilly
LLY
|
+$33.4M |
Sector Composition
| 1 | Healthcare | 99.98% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
McKesson
MCK
$116B
| – | – |
-35,040
|
|
||
52
Molina Healthcare
MOH
$7.53B
| – | – |
-27,540
|
|
||
|
MRUS
53
DELISTED
Merus
MRUS
| – | – |
-272,890
|
|
||
54
NeoGenomics
NEO
$1.04B
| – | – |
-391,110
|
|
||
55
Natera
NTRA
$26.6B
| – | – |
-65,130
|
|
||
56
Tenet Healthcare
THC
$19.8B
| – | – |
-518,990
|
|
||
57
Thermo Fisher Scientific
TMO
$178B
| – | – |
-51,240
|
|
||
58
UnitedHealth
UNH
$254B
| – | – |
-62,980
|
|
||
59
Dentsply Sirona
XRAY
$2.43B
| – | – |
-158,200
|
|
||
|
NVRO
60
DELISTED
NEVRO CORP.
NVRO
| – | – |
-67,600
|
|
||
|
RVNC
61
DELISTED
Revance Therapeutics, Inc.
RVNC
| – | – |
-64,590
|
|
||
|
SWAV
62
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| – | – |
-19,720
|
|
||
|
SGEN
63
DELISTED
Seagen Inc. Common Stock
SGEN
| – | – |
-57,340
|
|
||
|
CANO
64
DELISTED
Cano Health, Inc.
CANO
| – | – |
-3,956
|
|
||
|
LGV.WS
65
DELISTED
Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
LGV.WS
| – | – |
-149,999
|
|